Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01384604 · ClinicalTrials.gov registry record

Neurophysiological Studies in Schizophrenia and Psychiatric Disorders

A clinical trial, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
1,189
Enrollment target

NCT01384604: Completed study, sponsored by University of Texas Southwestern Medical Center.

NCT01384604 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 1,189 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01384604 has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
1,189 participants
Enrollment target

Study Summary

The overall goal of this project is to identify intermediate phenotypes for psychosis across the schizophrenia and bipolar disorders boundary with implications for future genetic studies. Recent studies provide considerable evidence that schizophrenia and psychotic bipolar disorder may share overlapping etiologic determinants. Identifying disease-related genetic effects is a major focus in schizophrenia and bipolar research, with enormous implications for diagnosis and treatment for these two disorders. Efforts have been multifaceted, with the ultimate goal of describing causal paths from specific genetic variants, to changes in neuronal functioning, to altered brain anatomy, to behavioral and functional impairments. Parallel efforts have identified and refined several alternative endophenotypes that are stable, heritable, have (partly) known biological substrates, and are associated with psychosis liability. Although many such endophenotypes have been individually studied in schizophrenia, and to a lesser extent in bipolar disorder, no study has comprehensively assessed a broad panel of these markers in the two disorders with parallel recruitment, and the extent to which they mark independent aspects of psychosis risk, or their overlap in the two disorders. In this research project, we will examine a broad panel of putative endophenotypes in affected individuals and their first degree, biological relatives in order to: 1) characterize the degree of familial phenotypic overlap between schizophrenia and psychotic bipolar disorders; 2) identify patterns of endophenotypes unique to the two disorders; and, 3) contrast the heritability of endophenotypes across the disorders. We will obtain measures of neurophysiology (e.g., eye tracking, P50 gating, PPI, and P300), neurocognition (e.g., attention/vigilance, episodic and working memory), and brain structure (e.g., volumes of gray and white matter in specified brain regions). Blood samples will also be collected and stored

Trial Details

FieldValue
Enrollment Target 1,189 participants
Start Date 2007-12
Est. Completion 2013-05

What the finished NCT01384604 record still lists

NCT01384604 is an observational study that tracks outcomes without assigning an intervention. Its 1,189 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT01384604 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01384604 about?

NCT01384604 is a clinical study titled "Neurophysiological Studies in Schizophrenia and Psychiatric Disorders". The overall goal of this project is to identify intermediate phenotypes for psychosis across the schizophrenia and bipolar disorders boundary with implications for future genetic studies. Recent studies provide considerable evidence that schizophrenia and psychotic bipolar disorder may share overlap...

What is the current status of trial NCT01384604?

This trial is currently completed. The enrollment target is 1,189 participants. The study started on 2007-12. Estimated completion is 2013-05.

Who is sponsoring clinical trial NCT01384604?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05580419 · 1,188 participants · NA

    Impact of 4PCP on Practitioner and Patient Outcomes

  • NCT06290869 · 1,188 participants · Phase 3

    Tobacco Education and Lung Health Study (TEAL)

  • NCT04293562 · 1,186 participants · Phase 3

    A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

  • NCT07177339 · 1,196 participants · Phase 3

    eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01384604, the US trial registry maintained by the National Library of Medicine. NCT01384604 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.